Analysts at Leerink Partnrs issued their FY2029 EPS estimates for shares of Merck & Co., Inc. in a research report issued to clients and investors on Friday, January 24th. Leerink Partnrs analyst D.
In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...
Shares of Grail, a maker of early-detection cancer screening tests, soared last week. Here are the key chart levels to watch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback